Adenocarcinoma: all 1,996 studies
Page 19 of 20. Open to participants first (369), then studies with results posted, then the rest; newest registration first within each.
- Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.Status unknownNCT01067053Phase 2
- Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyStatus unknownNCT01066195Phase 3
- A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung AdenocarcinomaCompletedNCT01051934Phase 1
- A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)TerminatedNCT01050283Phase 1
- Avoiding Surgery in Rectal Cancer After Pre-Operative TherapyStatus unknownNCT01047969Phase 2
- Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksStatus unknownNCT01037049Phase 2
- Modulation of the Immune Response in Patients With Pancreatic Tubular AdenocarcinomaStatus unknownNCT01021800Phase 2
- Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRICompletedNCT01020630Phase 2
- Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionStatus unknownNCT01015339Phase 3
- Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate AdenocarcinomaCompletedNCT01011751Phase 3
- Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerCompletedNCT01010945Phase 1
- A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic AdenocarcinomaCompletedNCT00998322Phase 2
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00989651Phase 1
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
- Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic CancerCompletedNCT00983268Phase 1
- Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideCompletedNCT00981162Phase 1
- Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach CancerCompletedNCT00978549Phase 3
- Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus CisplatinCompletedNCT00966914Phase 3
- Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal AdenocarcinomaStatus unknownNCT00964080Phase 1/2
- Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerStatus unknownNCT00963092
- Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic CancerStatus unknownNCT00947102
- TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung CancerCompletedNCT00940069Phase 2
- Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the PancreasCompletedNCT00918853Not applicable
- Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes ProstateCompletedNCT00915122Phase 1/2
- A Study of CP-4126 in Patients With Advanced Pancreatic CancerCompletedNCT00913198Phase 2
- Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate CancerCompletedNCT00911118Phase 1
- A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal AdenocarcinomasCompletedNCT00909402Phase 1
- Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal TissueCompletedNCT00909350
- Endoscopic Ultrasound Elastography in Pancreatic MassesCompletedNCT00909103
- Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PETCompletedNCT00904410Phase 4
- Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung AdenocarcinomaStatus unknownNCT00903292Not applicable
- YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyTerminatedNCT00899093
- Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer PatientsCompletedNCT00873353Phase 2
- Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach AdenocarcinomaTerminatedNCT00871273Phase 4
- Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After RadiochemotherapyCompletedNCT00855946
- Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic AdenocarcinomaCompletedNCT00854477Phase 4
- Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionCompletedNCT00849615Phase 2
- Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal ResectionCompletedNCT00844675Phase 4
- Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal AdenocarcinomaTerminatedNCT00827671Phase 2
- A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of LungCompletedNCT00816868Phase 2
- Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal AdenocarcinomaCompletedNCT00816543Phase 2
- Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00813072Phase 2
- Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and StomachWithdrawnNCT00800969Phase 2
- Patients Overexposed for a Prostate AdenocarcinomaCompletedNCT00773656
- A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-DocetaxelStatus unknownNCT00764166Phase 3
- Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT00763646Phase 2
- Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the UrotheliumActive, not recruitingNCT00756639Phase 2
- The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation TherapyStatus unknownNCT00751543Not applicable
- Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus CancerCompletedNCT00737373Phase 2
- Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General StatusCompletedNCT00733616Phase 2
- Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00732745Phase 1
- Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaWithdrawnNCT00728000Phase 2
- AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction CancerCompletedNCT00719550Phase 1/2
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerStatus unknownNCT00719303Phase 3
- Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal CancerCompletedNCT00707889Phase 2
- Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas AdenocarcinomaCompletedNCT00707278Phase 1
- The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus AdenocarcinomaStatus unknownNCT00674167Phase 2
- The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic AdenocarcinomaCompletedNCT00644254
- High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer PainSuspendedNCT00637364Phase 1/2
- Single Photon Emission Computed Tomography (SPECT) Lymph Node MappingCompletedNCT00608920Not applicable
- Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic AdenocarcinomaCompletedNCT00600002Phase 1
- A Phase I/Expansion Study of DasatinibTerminatedNCT00598091Phase 1
- Endoscopic Tri-Modal Imaging in Patients With Barrett's EsophagusCompletedNCT00586989
- Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the ProstateCompletedNCT00585962Phase 2
- Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard TreatmentTerminatedNCT00585845Phase 1
- Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal AdenocarcinomaCompletedNCT00583674Phase 2
- Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
- Safety Study of Modified Vaccinia Virus to CancerCompletedNCT00574977Phase 1
- Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and GemcitabineCompletedNCT00560963Phase 1/2
- A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT00558207Phase 2
- XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal AdenocarcinomaStatus unknownNCT00557713Phase 2
- Correlation of PET-CT Studies With Serum Protein AnalysisCompletedNCT00547742
- Comparison Between Colorectal Stents and Primary Surgery in Obstructive Colonic Cancer. A Randomized, Controlled StudyTerminatedNCT00514332Not applicable
- Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)CompletedNCT00511485Phase 2
- Identification of Key Blood Molecular Markers for ImmunotherapyTerminatedNCT00507702
- Phase I Irinotecan, 5-Fluorouracil and Leucovorin CombinationCompletedNCT00507091Phase 1
- A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract CancerCompletedNCT00504192Phase 2
- Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic AdenocarcinomaCompletedNCT00495924
- Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative ResectionCompletedNCT00464893Phase 2
- Sorafenib in BAC or Never-Smokers With Lung AdenocarcinomaCompletedNCT00456716Phase 2
- First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never SmokerCompletedNCT00455936Phase 3
- Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric CancerStatus unknownNCT00450203Phase 2/3
- Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal AdenocarcinomasCompletedNCT00443196Phase 2/3
- Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal CancerCompletedNCT00436657Phase 1
- Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By SurgeryCompletedNCT00433576Phase 1
- Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung AdenocarcinomaCompletedNCT00430261Phase 2
- A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate CancerCompletedNCT00430235Phase 2
- Study of Image-guided Dosimetry for Interstitial Prostate BrachytherapyCompletedNCT00426959Phase 1
- Sentinel Lymph Node Technique in Multifocal Breast CancerCompletedNCT00417495Phase 2
- Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With GemcitabineCompletedNCT00397787Phase 2
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic CancerCompletedNCT00395252Phase 2
- Therapeutic Strategy in Advanced Bronchioloalveolar CarcinomaCompletedNCT00384826Phase 2
- EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the PancreasCompletedNCT00377936Phase 2
- Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic CancerCompletedNCT00375310Phase 1
- Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal JunctionCompletedNCT00374985Phase 1/2
- Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube CancerCompletedNCT00357448Phase 1
- Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal AdenocarcinomaTerminatedNCT00353457Phase 2
- Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric AdenocarcinomaCompletedNCT00352833Phase 2
- Docetaxel in Locally Advanced Gastric AdenocarcinomaCompletedNCT00343239Phase 2